Laurel T. Bate-Eya

Mesoporous Silica Nanoparticles as Drug Delivery Systems for Targeted Inhibition of Notch Signaling in Cancer

Veronika Mamaeva, Jessica M. Rosenholm, Laurel T. Bate-Eya et al. · Molecular Therapy · 2011 · 216 citations · Full text

Cancer‐Cell‐Specific Induction of Apoptosis Using Mesoporous Silica Nanoparticles as Drug‐Delivery Vectors

Jessica M. Rosenholm, Emilia Peuhu, Laurel T. Bate-Eya et al. · Small · 2010 · 183 citations

Nanoparticles, Engineering, Cancer‐cell‐specific Induction +19

Newly-derived neuroblastoma cell lines propagated in serum-free media recapitulate the genotype and phenotype of primary neuroblastoma tumours

Laurel T. Bate-Eya, Marli E. Ebus, Jan Köster et al. · European Journal of Cancer · 2013 · 67 citations

Tumor Biology, Primary Neuroblastoma Tumours, Tumor Innervation +7

High efficacy of the BCL-2 inhibitor ABT199 (venetoclax) in BCL-2 high-expressing neuroblastoma cell lines and xenografts and rational for combination with MCL-1 inhibition

Laurel T. Bate-Eya, Ilona J.M. den Hartog, Ida van der Ploeg et al. · Oncotarget · 2016 · 60 citations · Full text

Enhancer of zeste homologue 2 plays an important role in neuroblastoma cell survival independent of its histone methyltransferase activity

Laurel T. Bate-Eya, Hinco J. Gierman, Marli E. Ebus et al. · European Journal of Cancer · 2017 · 35 citations

Chromatin, Developmental Biology, Chromatin Remodeling +8